BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

842 related articles for article (PubMed ID: 14994391)

  • 21. [Treatment of severe systemic autoimmune diseases with autologous peripheral blood stem cell transplantation].
    Zhao Y; Zhou DB; Leng XM; Wang SJ; Li TS; Duan Y; Shen T; Zhao YQ; Zhang JP; Bai LJ; Cui W; Zhang FQ; Zeng XF; Zhang FC; Dong Y; Tang FL
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2077-81. PubMed ID: 15730620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients.
    Traynor AE; Barr WG; Rosa RM; Rodriguez J; Oyama Y; Baker S; Brush M; Burt RK
    Arthritis Rheum; 2002 Nov; 46(11):2917-23. PubMed ID: 12428232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
    Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
    Cesaro S; Meloni G; Messina C; Pillon M; Proglia A; Lanino E; Caniggia M; Bagnulo S; Pession A; Locatelli F;
    Bone Marrow Transplant; 2001 Jul; 28(2):131-6. PubMed ID: 11509930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous stem cell transplantation for rheumatoid arthritis--interim report of 6 patients.
    Bingham SJ; Snowden J; McGonagle D; Richards S; Isaacs J; Morgan G; Emery P
    J Rheumatol Suppl; 2001 Oct; 64():21-4. PubMed ID: 11642498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
    Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis.
    Verburg RJ; Sont JK; Vliet Vlieland TP; Landewé RB; Boers M; Kievit J; van Laar JM
    J Rheumatol; 2001 Apr; 28(4):719-27. PubMed ID: 11327241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reduced intensity of BuCy conditioning regimen for transplantation in the treatment of malignant hematologic diseases].
    Chen H; Lu DP; Huang XJ; Liu KY; Xu LP; Han W; Ren HY; Chen YH; Liu DH; Lu J; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2005 May; 26(5):273-6. PubMed ID: 15949287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease.
    Tyndall A; Fassas A; Passweg J; Ruiz de Elvira C; Attal M; Brooks P; Black C; Durez P; Finke J; Forman S; Fouillard L; Furst D; Holmes J; Joske D; Jouet J; Kötter I; Locatelli F; Prentice H; Marmont AM; McSweeney P; Musso M; Peter HH; Snowden JA; Sullivan K; Gratwohl A
    Bone Marrow Transplant; 1999 Oct; 24(7):729-34. PubMed ID: 10516675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensified-dose (4 gm/m2) cyclophosphamide and granulocyte colony-stimulating factor administration for hematopoietic stem cell mobilization in refractory rheumatoid arthritis.
    Breban M; Dougados M; Picard F; Zompi S; Marolleau JP; Bocaccio C; Heshmati F; Mezieres M; Dreyfus F; Bouscary D
    Arthritis Rheum; 1999 Nov; 42(11):2275-80. PubMed ID: 10555020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation.
    Moore J; Ma D; Will R; Cannell P; Handel M; Milliken S
    Bone Marrow Transplant; 2004 Aug; 34(3):241-7. PubMed ID: 15235579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial.
    Sanmartí R; Marsal S; Valverde J; Casado E; Lafuente R; Kashiwagi N; Rodriguez-Cros JR; Erra A; Reina D; Gratacós J
    Rheumatology (Oxford); 2005 Sep; 44(9):1140-4. PubMed ID: 15927997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem cell transplantation for severe autoimmune diseases: progress and problems.
    Marmont AM
    Haematologica; 1998 Aug; 83(8):733-43. PubMed ID: 9793258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem cell transplantation for autoimmune disorders. Rheumatoid arthritis.
    Bingham SJ; Moore JJ
    Best Pract Res Clin Haematol; 2004 Jun; 17(2):263-76. PubMed ID: 15302339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
    Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease.
    Musso M; Porretto F; Crescimanno A; Bondi F; Polizzi V; Scalone R
    Am J Hematol; 2001 Feb; 66(2):75-9. PubMed ID: 11421302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
    Ogrendik M
    Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial.
    Matteson EL; Weyand CM; Fulbright JW; Christianson TJ; McClelland RL; Goronzy JJ
    Rheumatology (Oxford); 2004 May; 43(5):619-25. PubMed ID: 14983105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.